Palmoplantar pustular psoriasis induced by ocrelizumab in a patient affected by multiple sclerosis

Ital J Dermatol Venerol. 2022 Oct;157(5):459-460. doi: 10.23736/S2784-8671.22.07245-0.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Psoriasis* / chemically induced

Substances

  • Antibodies, Monoclonal, Humanized
  • ocrelizumab